EGFR and Estrogen Receptors in Non-Malignant Breast Tissue
Author Information
Author(s): S. Barker, C. Panahy, J.R. Puddefoot, A.W. Goode, G.P. Vinson
Primary Institution: Medical College of St Bartholomew's Hospital
Hypothesis
What is the relationship between epidermal growth factor receptor (EGFR) and estrogen receptor (ER) status in non-malignant breast tissue?
Conclusion
The study found that while EGFR is present in non-malignant breast tissue, there is no significant relationship between EGFR and ER expression in these samples.
Supporting Evidence
- 84% of non-malignant samples were EGFR positive.
- Only 29% of samples expressed both EGFR and ER.
- No significant relationship was found between ER and EGFR in non-malignant tissue.
Takeaway
This study looked at breast tissue that wasn't cancerous and found that two important receptors, EGFR and ER, can be present together, which is different from what happens in cancerous tissue.
Methodology
The study analyzed 51 samples of non-malignant breast tissue from mastectomies for EGFR and ER status using radioligand binding assays.
Limitations
The study only included samples from four mastectomies, which may limit the generalizability of the findings.
Participant Demographics
Two premenopausal patients aged 39 and two post-menopausal patients aged 74 and 77.
Statistical Information
P-Value
p<0.002
Statistical Significance
p<0.30
Want to read the original?
Access the complete publication on the publisher's website